BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29927013)

  • 1. Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study.
    Jansen F; Verdonck-de Leeuw IM; Cuijpers P; Leemans CR; Waterboer T; Pawlita M; Penfold C; Thomas SJ; Waylen A; Ness AR
    Psychooncology; 2018 Sep; 27(9):2245-2256. PubMed ID: 29927013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive Symptoms, Systemic Inflammation, and Survival Among Patients With Head and Neck Cancer.
    Cash E; Albert C; Palmer I; Polzin B; Kabithe A; Crawford D; Bumpous JM; Sephton SE
    JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):405-413. PubMed ID: 38546616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressive symptoms and actigraphy-measured circadian disruption predict head and neck cancer survival.
    Cash E; Duck CR; Brinkman C; Rebholz W; Albert C; Worthen M; Jusufbegovic M; Wilson L; Bumpous JM
    Psychooncology; 2018 Oct; 27(10):2500-2507. PubMed ID: 30117225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The course of symptoms of anxiety and depression from time of diagnosis up to 2 years follow-up in head and neck cancer patients treated with primary (chemo)radiation.
    van Beek FE; Jansen F; Mak L; Lissenberg-Witte BI; Buter J; Vergeer MR; Voortman J; Cuijpers P; Leemans CR; Verdonck-de Leeuw IM
    Oral Oncol; 2020 Mar; 102():104576. PubMed ID: 32028135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A screening algorithm for early detection of major depressive disorder in head and neck cancer patients post-treatment: Longitudinal study.
    Henry M; Rosberger Z; Ianovski LE; Hier M; Zeitouni A; Kost K; Mlynarek A; Black M; MacDonald C; Richardson K; Zhang X; Fuhrmann F; Chartier G; Frenkiel S
    Psychooncology; 2018 Jun; 27(6):1622-1628. PubMed ID: 29532541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttraumatic growth among head and neck cancer survivors with psychological distress.
    Holtmaat K; van der Spek N; Cuijpers P; Leemans CR; Verdonck-de Leeuw IM
    Psychooncology; 2017 Jan; 26(1):96-101. PubMed ID: 26918531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of psychiatric diagnoses to extent of opioid prescription in the first year post-head and neck cancer diagnosis: A longitudinal study.
    Henry M; Alias A; Frenkiel S; Richardson K; Hier M; Zeitouni A; Kost K; Mlynarek A; Black M; MacDonald C; Chartier G; Rosberger Z
    Psychooncology; 2019 Jan; 28(1):107-115. PubMed ID: 30308695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?
    Choi SH; Terrell JE; Bradford CR; Ghanem T; Spector ME; Wolf GT; Lipkus IM; Duffy SA
    Nicotine Tob Res; 2016 Dec; 18(12):2216-2224. PubMed ID: 27613928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal study of distress (depression and anxiety) up to 18 months after radiotherapy for head and neck cancer.
    Neilson K; Pollard A; Boonzaier A; Corry J; Castle D; Smith D; Trauer T; Couper J
    Psychooncology; 2013 Aug; 22(8):1843-8. PubMed ID: 23239423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive symptoms, social anxiety, and perceived neck function in patients with head and neck cancer.
    Rhoten BA; Murphy BA; Dietrich MS; Ridner SH
    Head Neck; 2018 Jul; 40(7):1443-1452. PubMed ID: 29573016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression, anxiety, quality of life, and predictors of depressive disorders in caregivers of patients with head and neck cancer: A six-month follow-up study.
    Lee CY; Lee Y; Wang LJ; Chien CY; Fang FM; Lin PY
    J Psychosom Res; 2017 Sep; 100():29-34. PubMed ID: 28789790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperlipidemia and statins use for the risk of new-onset anxiety/depression in patients with head and neck cancer: A population-based study.
    Huang CI; Lin LC; Tien HC; Que J; Ting WC; Chen PC; Wu HM; Ho CH; Wang JJ; Wang RH; Yang CC
    PLoS One; 2017; 12(3):e0174574. PubMed ID: 28362860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in head and neck cancer survivors: impact of pretreatment depressive symptoms.
    Howren MB; Christensen AJ; Karnell LH; Funk GF
    Health Psychol; 2010 Jan; 29(1):65-71. PubMed ID: 20063937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contextual and historical factors for increased levels of anxiety and depression in patients with head and neck cancer: A prospective longitudinal study.
    Henry M; Fuehrmann F; Hier M; Zeitouni A; Kost K; Richardson K; Mlynarek A; Black M; MacDonald C; Chartier G; Zhang X; Rosberger Z; Frenkiel S
    Head Neck; 2019 Aug; 41(8):2538-2548. PubMed ID: 30887617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression as a predictor of postoperative functional performance status (PFPS) and treatment adherence in head and neck cancer patients: a prospective study.
    Barber B; Dergousoff J; Nesbitt M; Mitchell N; Harris J; O'Connell D; Côté D; Biron V; Seikaly H
    J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):38. PubMed ID: 26385356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Changes in Depression Symptoms and Survival Among Patients With Lung Cancer: A National Cohort Assessment.
    Sullivan DR; Forsberg CW; Ganzini L; Au DH; Gould MK; Provenzale D; Slatore CG
    J Clin Oncol; 2016 Nov; 34(33):3984-3991. PubMed ID: 27996350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk and Clinical Risk Factors Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Squamous Cell Carcinoma Survivors.
    Aggarwal P; Goepfert RP; Garden AS; Garg N; Zaveri JS; Du XL; Swartz MD; Lai SY; Fuller CD; Ferrarotto R; Sturgis EM; Piller LB; Hutcheson KA
    JAMA Otolaryngol Head Neck Surg; 2021 May; 147(5):469-478. PubMed ID: 33538759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety and depression in patients after surgery for head and neck cancer in Japan.
    Suzuki M; Deno M; Myers M; Asakage T; Takahashi K; Saito K; Mori Y; Saito H; Ichikawa Y; Yamamoto-Mitani N; Miyashita M
    Palliat Support Care; 2016 Jun; 14(3):269-77. PubMed ID: 27210590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic impact of depression or depressive symptoms on patients with head and neck cancer: A systematic review and meta-analysis.
    Van der Elst S; Bardash Y; Wotman M; Kraus D; Tham T
    Head Neck; 2021 Nov; 43(11):3608-3617. PubMed ID: 34525238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do depressive symptoms predict cancer incidence?: 17-year follow-up of the Whitehall II study.
    Archer G; Pikhart H; Head J
    J Psychosom Res; 2015 Dec; 79(6):595-603. PubMed ID: 26299450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.